$ITMN Recent News 6 stocks to watch 3:25 p.m.
Post# of 74540
Posted On: 06/03/2014 9:34:41 AM
$ITMN Recent News
6 stocks to watch 3:25 p.m. May 29, 2014 - The Trading Deck
Charting the Nasdaq’s technical breakout 12:34 p.m. May 27, 2014 - Michael Ashbaugh
Charting the Nasdaq’s technical breakout 12:05 p.m. May 27, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 7, 2014 - The Trading Deck
InterMune slips off lofty perch while Aegerion's earnings disappoint 12:26 p.m. Feb. 26, 2014 - Russ Britt
'Bad' weather heads west, retailers report, and don't short addiction 8:06 a.m. Feb. 26, 2014 - Shawn Langlois
InterMune's big day lifts ETF, biotech index to record highs 5:44 p.m. Feb. 25, 2014 - Russ Britt
InterMune shares more than double on tests for lung-disease treatment 12:27 p.m. Feb. 25, 2014 - Russ Britt
Biogen, InterMune, Alkermes all make stock waves with earnings 2:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 4:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 5:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 10:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 6:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 3:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 12:27 p.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 4:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 12:28 p.m. March 15, 2012 - Val Brickates Kennedy
InterMune Resubmits Esbriet NDA - Analyst Blog 6:18 p.m. May 28, 2014 - Zacks.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog 11:16 a.m. May 28, 2014 - Zacks.com
Intermune resubmits NDA 8:24 a.m. May 27, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ITMN CAB SPWH DKS OPK YHOO 6:00 a.m. May 23, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: What Was Bad Is Good Again 7:54 p.m. May 22, 2014 - TheStreet.com
Additional Data on InterMune's Esbriet - Analyst Blog 5:05 p.m. May 21, 2014 - Zacks.com
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
InterMune Up on Esbriet Data Presentation - Analyst Blog 4:30 p.m. May 20, 2014 - Zacks.com
InterMune Offers Added Pirfenidone Data in Idiopathic Pulmonary Fibrosis, Says Endpoint Was Met with Statistical Significance in Capacity 2 4:03 p.m. May 20, 2014 - benzinga.com
InterMune (ITMN) Jumps: Stock Moves 13.4% Higher - Tale of the Tape 9:25 a.m. May 20, 2014 - Zacks.com
Why InterMune (ITMN) Stock Surged to a One-Year High Today 2:16 p.m. May 19, 2014 - TheStreet.com
Jim Cramer's Stop Trading: InterMune Shoots Higher, Zillow Could Too 11:15 a.m. May 19, 2014 - TheStreet.com
UPDATE: Investors Bullish On InterMune After Leerlink Upgrade 10:50 a.m. May 19, 2014 - benzinga.com
InterMune Higher on Superior Lung Drug Data, FDA Resubmission Next 10:39 a.m. May 19, 2014 - TheStreet.com
Benzinga's Volume Movers 9:27 a.m. May 19, 2014 - benzinga.com
Will This Analyst Upgrade Help InterMune (ITMN) Stock Today? 9:20 a.m. May 19, 2014 - TheStreet.com
Morning Market Movers 8:45 a.m. May 19, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. May 19, 2014 - benzinga.com
Pirfenidone Phase 3 achieves primary endpoint 10:53 p.m. May 18, 2014 - Seeking Alpha
Lung Drug Data Showdown: InterMune vs. Boehringer Ingelheim 5:05 p.m. May 18, 2014 - TheStreet.com
Critical Alerts For Macy's, Western Digital, InterMune, Merck, and Time Warner Released By InvestorsObserver 9:31 a.m. May 28, 2014 - PR Newswire - PRF
InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF 7:00 a.m. May 27, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis 5:00 p.m. May 20, 2014 - PR Newswire - PRF
Morning Coverage of Equities Reaching New Highs -- Research on InterMune, Zillow, ICICI Bank, and Zendesk 11:14 a.m. May 20, 2014 - PR Newswire - PRF
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine 5:02 p.m. May 18, 2014 - PR Newswire - PRF
IDIOPATHIC PULMONARY FIBROSIS PATIENTS TO HAVE EXPANDED ACCESS TO THERAPY 8:12 a.m. May 16, 2014 - GlobeNewswire
InterMune Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States 8:00 a.m. May 16, 2014 - PR Newswire - PRF
InterMune Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting 8:00 a.m. May 12, 2014 - PR Newswire - PRF
InterMune Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights 4:01 p.m. May 1, 2014 - PR Newswire - PRF
InterMune To Release First Quarter Financial Results On May 1 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray 8:00 a.m. March 14, 2014 - PR Newswire - PRF
InterMune Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock 7:20 p.m. March 13, 2014 - PR Newswire - PRF
InterMune Announces Proposed Public Offering of Common Stock 4:02 p.m. March 12, 2014 - PR Newswire - PRF
Top Gainers under the Lens: Advanced Micro Devices, Big Lots, InterMune, and Palo Alto Networks 1:38 p.m. March 10, 2014 - PR Newswire - PRF
Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California 9:05 a.m. March 10, 2014 - PR Newswire - PRF
Critical Alerts For InterMune, Infinity Pharmaceuticals, Zulily, Intrexon, and Polypore International Released By InvestorsObserver 10:31 a.m. Feb. 26, 2014 - PR Newswire - PRF
Consensus Earnings Forecast for BlackBerry, AT&T, Micron, InterMune, RF Micro Devices, and Coca-Cola 10:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Office Depot Offers Disappointing Outlook; InterMune Soars 170% to Record High on Phase 3 Test Results 1:25 a.m. Feb. 26, 2014 - ACCESSWIRE
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF) 8:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
6 stocks to watch 3:25 p.m. May 29, 2014 - The Trading Deck
Charting the Nasdaq’s technical breakout 12:34 p.m. May 27, 2014 - Michael Ashbaugh
Charting the Nasdaq’s technical breakout 12:05 p.m. May 27, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 7, 2014 - The Trading Deck
InterMune slips off lofty perch while Aegerion's earnings disappoint 12:26 p.m. Feb. 26, 2014 - Russ Britt
'Bad' weather heads west, retailers report, and don't short addiction 8:06 a.m. Feb. 26, 2014 - Shawn Langlois
InterMune's big day lifts ETF, biotech index to record highs 5:44 p.m. Feb. 25, 2014 - Russ Britt
InterMune shares more than double on tests for lung-disease treatment 12:27 p.m. Feb. 25, 2014 - Russ Britt
Biogen, InterMune, Alkermes all make stock waves with earnings 2:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 4:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 5:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 10:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 6:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 3:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 12:27 p.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 4:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 12:28 p.m. March 15, 2012 - Val Brickates Kennedy
InterMune Resubmits Esbriet NDA - Analyst Blog 6:18 p.m. May 28, 2014 - Zacks.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog 11:16 a.m. May 28, 2014 - Zacks.com
Intermune resubmits NDA 8:24 a.m. May 27, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ITMN CAB SPWH DKS OPK YHOO 6:00 a.m. May 23, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: What Was Bad Is Good Again 7:54 p.m. May 22, 2014 - TheStreet.com
Additional Data on InterMune's Esbriet - Analyst Blog 5:05 p.m. May 21, 2014 - Zacks.com
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
InterMune Up on Esbriet Data Presentation - Analyst Blog 4:30 p.m. May 20, 2014 - Zacks.com
InterMune Offers Added Pirfenidone Data in Idiopathic Pulmonary Fibrosis, Says Endpoint Was Met with Statistical Significance in Capacity 2 4:03 p.m. May 20, 2014 - benzinga.com
InterMune (ITMN) Jumps: Stock Moves 13.4% Higher - Tale of the Tape 9:25 a.m. May 20, 2014 - Zacks.com
Why InterMune (ITMN) Stock Surged to a One-Year High Today 2:16 p.m. May 19, 2014 - TheStreet.com
Jim Cramer's Stop Trading: InterMune Shoots Higher, Zillow Could Too 11:15 a.m. May 19, 2014 - TheStreet.com
UPDATE: Investors Bullish On InterMune After Leerlink Upgrade 10:50 a.m. May 19, 2014 - benzinga.com
InterMune Higher on Superior Lung Drug Data, FDA Resubmission Next 10:39 a.m. May 19, 2014 - TheStreet.com
Benzinga's Volume Movers 9:27 a.m. May 19, 2014 - benzinga.com
Will This Analyst Upgrade Help InterMune (ITMN) Stock Today? 9:20 a.m. May 19, 2014 - TheStreet.com
Morning Market Movers 8:45 a.m. May 19, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. May 19, 2014 - benzinga.com
Pirfenidone Phase 3 achieves primary endpoint 10:53 p.m. May 18, 2014 - Seeking Alpha
Lung Drug Data Showdown: InterMune vs. Boehringer Ingelheim 5:05 p.m. May 18, 2014 - TheStreet.com
Critical Alerts For Macy's, Western Digital, InterMune, Merck, and Time Warner Released By InvestorsObserver 9:31 a.m. May 28, 2014 - PR Newswire - PRF
InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF 7:00 a.m. May 27, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis 5:00 p.m. May 20, 2014 - PR Newswire - PRF
Morning Coverage of Equities Reaching New Highs -- Research on InterMune, Zillow, ICICI Bank, and Zendesk 11:14 a.m. May 20, 2014 - PR Newswire - PRF
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine 5:02 p.m. May 18, 2014 - PR Newswire - PRF
IDIOPATHIC PULMONARY FIBROSIS PATIENTS TO HAVE EXPANDED ACCESS TO THERAPY 8:12 a.m. May 16, 2014 - GlobeNewswire
InterMune Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States 8:00 a.m. May 16, 2014 - PR Newswire - PRF
InterMune Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting 8:00 a.m. May 12, 2014 - PR Newswire - PRF
InterMune Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights 4:01 p.m. May 1, 2014 - PR Newswire - PRF
InterMune To Release First Quarter Financial Results On May 1 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray 8:00 a.m. March 14, 2014 - PR Newswire - PRF
InterMune Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock 7:20 p.m. March 13, 2014 - PR Newswire - PRF
InterMune Announces Proposed Public Offering of Common Stock 4:02 p.m. March 12, 2014 - PR Newswire - PRF
Top Gainers under the Lens: Advanced Micro Devices, Big Lots, InterMune, and Palo Alto Networks 1:38 p.m. March 10, 2014 - PR Newswire - PRF
Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California 9:05 a.m. March 10, 2014 - PR Newswire - PRF
Critical Alerts For InterMune, Infinity Pharmaceuticals, Zulily, Intrexon, and Polypore International Released By InvestorsObserver 10:31 a.m. Feb. 26, 2014 - PR Newswire - PRF
Consensus Earnings Forecast for BlackBerry, AT&T, Micron, InterMune, RF Micro Devices, and Coca-Cola 10:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Office Depot Offers Disappointing Outlook; InterMune Soars 170% to Record High on Phase 3 Test Results 1:25 a.m. Feb. 26, 2014 - ACCESSWIRE
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF) 8:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼